VINS Bioproducts completes Phase 2 clinical trials of COVID antidote VINCOV-19 Ruchika Sharma13 Oct 2022 11:15 AM ISTHyderabad: VINS Bioproducts Limited, an immunological company, based in Hyderabad, in collaboration with the Centre for Cellular and...
Pfizer COVID vaccine clears Japan panel for use with young children Ruchika Sharma7 Oct 2022 3:30 PM ISTTokyo: A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc's COVID-19 vaccine for children as young as six months old.Japan...
COVID booster significantly improves protection against Omicron hospitalization: JAMA Dr. Kamal Kant Kohli3 Oct 2022 6:00 PM ISTCHICAGO: A US case-control research published in JAMA Network shows that, three doses of an mRNA COVID-19 vaccination were associated with a 59% lower...
Pfizer, BioNTech complete submission to EMA for Omicron BA.4/BA.5-Adapted Bivalent vaccine booster in children aged 5 Through 11 years Ruchika Sharma2 Oct 2022 3:45 PM ISTCOMIRNATY, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster for Children aged 5 through 11 years Ruchika Sharma27 Sept 2022 11:15 AM ISTCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
Moderna seeks USFDA nod for Omicron-targeted COVID vaccine for adolescents, children Ruchika Sharma25 Sept 2022 10:30 AM ISTUS: Moderna Inc said on Friday it has requested U.S. authorization for use of its Omicron-targeting COVID vaccine in adolescents and children.The...
COVID-19 Treatment: GSK Sotrovimab, Roche antibody cocktail casirivimab-imdevimab no longer recommended by WHO Ruchika Sharma22 Sept 2022 4:14 PM ISTBoth therapies continue to be recommended for use by the European drugs regulator.
Pfizer, BioNTech Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster get CHMP nod Ruchika Sharma14 Sept 2022 11:37 AM ISTIf an authorization is granted, the Pfizer-BioNTech bivalent Omicron BA.4/BA.5 COVID-19 vaccine will be available within the coming days to all 27 EU...
Vaccine substitute- Two antibodies capable of fighting all known COVID strains identified in Israel Dr. Kamal Kant Kohli10 Sept 2022 9:00 AM ISTResearchers at Tel Aviv University have been able to identify two antibodies capable of fighting all known COVID-19 strains. They have noted that...
GSK, Sanofi see EU drugs regulator decision on COVID booster in weeks Ruchika Sharma6 Sept 2022 2:00 PM ISTThe vaccine could be used as a booster for people who had received any other COVID-19 vaccine, Triomphe said.
Pfizer-BioNTech bivalent booster for Omicron, original COVID strain gets UK nod Ruchika Sharma5 Sept 2022 12:45 PM ISTIn each dose of the booster vaccine called "Comirnaty bivalent Original/Omicron", half of the vaccine (15 micrograms) targets the original virus...
EMA on alert over new variants of COVID: Official Ruchika Sharma5 Sept 2022 11:30 AM ISTOn Thursday, the EMA ’s human medicines committee (CHMP) recommended the use of two vaccines adapted against the Omicron variant of Covid-19 from...
